Nurit Yanay

Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the <i>dy^2J/dy^2J</i> Mouse

Nurit Yanay, Shlomit Aga‐Mizrachi, Zivia Brunschwig et al. · Annals of Neurology · 2011 · 79 citations

Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery

Stella Mitrani‐Rosenbaum, L. Yakovlev, Michal Becker‐Cohen et al. · Neuromuscular Disorders · 2012 · 37 citations

Regenerative Medicine, Translational Medicine, Cell Therapy +8

Variable Phenotypes of Knockin Mice Carrying the M712T Gne Mutation

Ilan Sela, L. Yakovlev, Michal Becker‐Cohen et al. · NeuroMolecular Medicine · 2012 · 32 citations

Knockout Mouse, Immunogenetics, Developmental Biology +4

Nerve growth factor stimulation of ERK1/2 phosphorylation requires both p75NTR and α9β1 integrin and confers myoprotection towards ischemia in C2C12 skeletal muscle cell model

Keren Ettinger, Shimon Lecht, Hadar Arien‐Zakay et al. · Cellular Signalling · 2012 · 23 citations

Muscle Function, α9β1 Integrin, Peripheral Nerves +17

The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy

Yoram Nevo, Shlomit Aga‐Mizrachi, Edva Elmakayes et al. · PLoS ONE · 2011 · 21 citations · Full text

Muscle Function, Immunology, Ras Expression +23